LMAT
Lemaitre Vascular Inc

519
Mkt Cap
$2.63B
Volume
333,631.00
52W High
$115.33
52W Low
$71.42
PE Ratio
43.01
LMAT Fundamentals
Price
$107.40
Prev Close
$108.18
Open
$106.20
50D MA
$86.96
Beta
0.72
Avg. Volume
144,606.80
EPS (Annual)
$2.52
P/B
6.48
Rev/Employee
$381,071.76
$1,686.01
Loading...
Loading...
News
all
press releases
LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
Zacks·9h ago
News Placeholder
More News
News Placeholder
LMAT Crosses Above Average Analyst Target
In recent trading, shares of LeMaitre Vascular Inc (Symbol: LMAT) have crossed above the average analyst 12-month target price of $101.62, changing hands for $113.69/share. When a stock reaches the...
Nasdaq News: Markets·3d ago
News Placeholder
LeMaitre Vascular (NASDAQ:LMAT) Price Target Raised to $105.00
Barrington Research raised their price objective on shares of LeMaitre Vascular from $95.00 to $105.00 and gave the stock an "outperform" rating in a research report on Thursday...
MarketBeat·4d ago
News Placeholder
Roth Mkm Reaffirms Buy Rating for LeMaitre Vascular (NASDAQ:LMAT)
Roth Mkm reaffirmed a "buy" rating and issued a $117.00 price objective (up from $108.00) on shares of LeMaitre Vascular in a research report on Thursday...
MarketBeat·4d ago
News Placeholder
Breaking Down LeMaitre Vascular: 4 Analysts Share Their Views
read more...
Benzinga·4d ago
News Placeholder
Wells Fargo & Company Issues Positive Forecast for LeMaitre Vascular (NASDAQ:LMAT) Stock Price
Wells Fargo & Company upped their target price on LeMaitre Vascular from $87.00 to $94.00 and gave the stock an "equal weight" rating in a research report on Thursday...
MarketBeat·4d ago
News Placeholder
LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year High After Strong Earnings
LeMaitre Vascular (NASDAQ:LMAT) Sets New 12-Month High on Strong Earnings...
MarketBeat·4d ago
News Placeholder
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Expected to Rise, Citizens Jmp Analyst Says
Citizens Jmp increased their price objective on LeMaitre Vascular from $113.00 to $118.00 and gave the company a "market outperform" rating in a report on Thursday...
MarketBeat·4d ago
News Placeholder
LeMaitre Vascular Q4 Earnings Call Highlights
LeMaitre Vascular (NASDAQ:LMAT) management highlighted fourth-quarter and full-year 2025 operating leverage, strong international growth, and an expanding commercial footprint during the company's Q4...
MarketBeat·5d ago
News Placeholder
LeMaitre Vascular (NASDAQ:LMAT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS
LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) issued its quarterly earnings results on Wednesday. The medical instruments supplier reported $0.68 earnings per share for the quarter, beating the...
MarketBeat·5d ago
<
1
2
...
>

Latest LMAT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.